From bacterial killing to immune modulation: Recent insights into the functions of lysozyme

PLoS Pathogens

Volumn 13, Issue 9, 2017, Pages

  Ragland, Stephanie A ^a   Criss, Alison K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; INFLAMMASOME; LYSOZYME; PATTERN RECOGNITION RECEPTOR; PEPTIDOGLYCAN; TEICHOIC ACID; ANTIINFECTIVE AGENT;

BACILLUS ANTHRACIS; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; DEACETYLATION; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE BACTERIUM; HELICOBACTER PYLORI; HOST CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; LACTOBACILLUS PLANTARUM; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PROTEIN ACETYLATION; PROTEIN CROSS LINKING; R FACTOR; REVIEW; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS INIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SUIS; TRANSCRIPTION REGULATION; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; DRUG EFFECTS; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; IMMUNE SYSTEM PHENOMENA; MURAMIDASE; PEPTIDOGLYCAN;

EID: 85030466874     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006512     Document Type: Review

References (138)

1. Callewaert L, Michiels CW, (2010) Lysozymes in the animal kingdom. J Biosci. 35(1):127–60. 20413917.
2. Lelouard H, Henri S, De Bovis B, Mugnier B, Chollat-Namy A, Malissen B, et al. (2010) Pathogenic bacteria and dead cells are internalized by a unique subset of Peyer's patch dendritic cells that express lysozyme. Gastroenterology. 138(1):173–84 e1-3. doi: 10.1053/j.gastro.2009.09.051 19800337.
3. Pipe RK, (1990) Hydrolytic enzymes associated with the granular haemocytes of the marine mussel Mytilus edulis. Histochem. 22(11):595–603. 2074209.
4. Fleming A, (1922) On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc London. 93:306–17.
5. Turner RD, Vollmer W, Foster SJ, (2014) Different walls for rods and balls: the diversity of peptidoglycan. Mol Microbiol. 91(5):862–74. doi: 10.1111/mmi.12513 24405365; PubMed Central PMCID: PMCPMC4015370.
6. Vollmer W, Seligman SJ, (2010) Architecture of peptidoglycan: more data and more models. Trends Microbiol. 18(2):59–66. doi: 10.1016/j.tim.2009.12.004 20060721.
7. Nash JA, Ballard TN, Weaver TE, Akinbi HT, (2006) The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo. J Immunol. 177(1):519–26. 16785549.
8. Derde M, Lechevalier V, Guerin-Dubiard C, Cochet MF, Jan S, Baron F, et al. (2013) Hen egg white lysozyme permeabilizes Escherichia coli outer and inner membranes. J Agric Food Chem. 61(41):9922–9. doi: 10.1021/jf4029199 24047287.
9. Zhang X, Jiang A, Yu H, Xiong Y, Zhou G, Qin M, et al. (2016) Human Lysozyme Synergistically Enhances Bactericidal Dynamics and Lowers the Resistant Mutant Prevention Concentration for Metronidazole to Helicobacter pylori by Increasing Cell Permeability. Molecules. 21(11). doi: 10.3390/molecules21111435 27801837.
10. Hancock RE, Diamond G, (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8(9):402–10. 10989307.
11. Davis KM, Weiser JN, (2011) Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect Immun. 79(2):562–70. doi: 10.1128/IAI.00651-10 21041496; PubMed Central PMCID: PMCPMC3028845.
12. Vollmer W, Tomasz A, (2000) The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae. J Biol Chem. 275(27):20496–501. doi: 10.1074/jbc.M910189199 10781617.
13. Vollmer W, Tomasz A, (2002) Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae. Infect Immun. 70(12):7176–8. doi: 10.1128/IAI.70.12.7176-7178.2002 12438406; PubMed Central PMCID: PMCPMC133073.
14. Wang G, Maier SE, Lo LF, Maier G, Dosi S, Maier RJ, (2010) Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect Immun. 78(11):4660–6. doi: 10.1128/IAI.00307-10 20805339; PubMed Central PMCID: PMCPMC2976313.
15. Boneca IG, Dussurget O, Cabanes D, Nahori MA, Sousa S, Lecuit M, et al. (2007) A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci U S A. 104(3):997–1002. doi: 10.1073/pnas.0609672104 17215377; PubMed Central PMCID: PMCPMC1766339.
16. Fittipaldi N, Sekizaki T, Takamatsu D, de la Cruz Dominguez-Punaro M, Harel J, Bui NK, et al. (2008) Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol Microbiol. 70(5):1120–35. doi: 10.1111/j.1365-2958.2008.06463.x 18990186.
17. Kaoukab-Raji A, Biskri L, Bernardini ML, Allaoui A, (2012) Characterization of SfPgdA, a Shigella flexneri peptidoglycan deacetylase required for bacterial persistence within polymorphonuclear neutrophils. Microbes Infect. 14(7–8):619–27. doi: 10.1016/j.micinf.2012.01.009 22307019.
18. Benachour A, Ladjouzi R, Le Jeune A, Hebert L, Thorpe S, Courtin P, et al. (2012) The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence. J Bacteriol. 194(22):6066–73. doi: 10.1128/JB.00981-12 22961856; PubMed Central PMCID: PMCPMC3486378.
19. Hebert L, Courtin P, Torelli R, Sanguinetti M, Chapot-Chartier MP, Auffray Y, et al. (2007) Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance. Infect Immun. 75(11):5390–8. doi: 10.1128/IAI.00571-07 17785473; PubMed Central PMCID: PMCPMC2168276.
20. Milani CJ, Aziz RK, Locke JB, Dahesh S, Nizet V, Buchanan JT, (2010) The novel polysaccharide deacetylase homologue Pdi contributes to virulence of the aquatic pathogen Streptococcus iniae. Microbiology. 156(Pt 2):543–54. doi: 10.1099/mic.0.028365-0 19762441; PubMed Central PMCID: PMCPMC2890087.
21. Ho TD, Williams KB, Chen Y, Helm RF, Popham DL, Ellermeier CD, (2014) Clostridium difficile extracytoplasmic function sigma factor sigmaV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection. Infect Immun. 82(6):2345–55. doi: 10.1128/IAI.01483-13 24664503; PubMed Central PMCID: PMCPMC4019185.
22. Yang S, Zhang F, Kang J, Zhang W, Deng G, Xin Y, et al (2014) Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression, and peptidoglycan deacetylase activity. BMC Microbiol. 14:174. doi: 10.1186/1471-2180-14-174 24975018; PubMed Central PMCID: PMCPMC4087242.
23. Nikaido H, (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev. 67(4):593–656. doi: 10.1128/MMBR.67.4.593-656.2003 14665678; PubMed Central PMCID: PMCPMC309051.
24. Wang G, Lo LF, Forsberg LS, Maier RJ, (2012) Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host. MBio. 3(6):e00409–12. doi: 10.1128/mBio.00409-12 23221800; PubMed Central PMCID: PMCPMC3517862.
25. Ellison RT III, Giehl TJ, (1991) Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest. 88(4):1080–91. doi: 10.1172/JCI115407 1918365; PubMed Central PMCID: PMCPMC295557.
26. Pushkaran AC, Nataraj N, Nair N, Gotz F, Biswas R, Mohan CG, (2015) Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay. J Chem Inf Model. 55(4):760–70. doi: 10.1021/ci500734k 25774564.
27. Moynihan PJ, Clarke AJ, (2011) O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems. Int J Biochem Cell Biol. 43(12):1655–9. doi: 10.1016/j.biocel.2011.08.007 21889603.
28. Bera A, Herbert S, Jakob A, Vollmer W, Gotz F, (2005) Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol. 55(3):778–87. doi: 10.1111/j.1365-2958.2004.04446.x 15661003.
29. Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, Becker CA, et al. (2010) Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe. 7(1):38–49. doi: 10.1016/j.chom.2009.12.008 20114027; PubMed Central PMCID: PMCPMC2818986.
30. Davis KM, Akinbi HT, Standish AJ, Weiser JN, (2008) Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 4(12):e1000241. doi: 10.1371/journal.ppat.1000241 19079576; PubMed Central PMCID: PMCPMC2587705.
31. Rae CS, Geissler A, Adamson PC, Portnoy DA, (2011) Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways. Infect Immun. 79(9):3596–606. doi: 10.1128/IAI.00077-11 21768286; PubMed Central PMCID: PMCPMC3165460.
32. Laaberki MH, Pfeffer J, Clarke AJ, Dworkin J, (2011) O-Acetylation of peptidoglycan is required for proper cell separation and S-layer anchoring in Bacillus anthracis. J Biol Chem. 286(7):5278–88. doi: 10.1074/jbc.M110.183236 21135105; PubMed Central PMCID: PMCPMC3037640.
33. Bernard E, Rolain T, Courtin P, Guillot A, Langella P, Hols P, et al. (2011) Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan. J Biol Chem. 286(27):23950–8. doi: 10.1074/jbc.M111.241414 21586574; PubMed Central PMCID: PMCPMC3129176.
34. Iwata T, Watanabe A, Kusumoto M, Akiba M, (2016) Peptidoglycan Acetylation of Campylobacter jejuni Is Essential for Maintaining Cell Wall Integrity and Colonization in Chicken Intestines. Appl Environ Microbiol. 82(20):6284–90. doi: 10.1128/AEM.02068-16 27520822; PubMed Central PMCID: PMCPMC5068153.
35. Dillard JP, Hackett KT, (2005) Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun. 73(9):5697–705. doi: 10.1128/IAI.73.9.5697-5705.2005 16113287; PubMed Central PMCID: PMCPMC1231103.
36. Ragland SA, Schaub RE, Hackett KT, Dillard JP, Criss AK, (2016) Two lytic transglycosylases in Neisseria gonorrhoeae impart resistance to killing by lysozyme and human neutrophils. Cell Microbiol. doi: 10.1111/cmi.12662 27597434.
37. Criss AK, Seifert HS, (2012) A bacterial siren song: intimate interactions between Neisseria and neutrophils. Nat Rev Microbiol. 10(3):178–90. Epub 2012/02/01. nrmicro2713 [pii] doi: 10.1038/nrmicro2713 22290508.
38. Blackburn NT, Clarke AJ, (2002) Characterization of soluble and membrane-bound family 3 lytic transglycosylases from Pseudomonas aeruginosa. Biochemistry. 41(3):1001–13. 11790124.
39. Veyrier FJ, Williams AH, Mesnage S, Schmitt C, Taha MK, Boneca IG, (2013) De-O-acetylation of peptidoglycan regulates glycan chain extension and affects in vivo survival of Neisseria meningitidis. Mol Microbiol. 87(5):1100–12. doi: 10.1111/mmi.12153 23373517.
40. Ha R, Frirdich E, Sychantha D, Biboy J, Taveirne ME, Johnson JG, et al. (2016) Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni. J Biol Chem. 291(43):22686–702. doi: 10.1074/jbc.M116.746404 27474744; PubMed Central PMCID: PMCPMC5077204.
41. Raymond JB, Mahapatra S, Crick DC, Pavelka MS, Jr (2005) Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J Biol Chem. 280(1):326–33. doi: 10.1074/jbc.M411006200 15522883.
42. Coulombe F, Divangahi M, Veyrier F, de Leseleuc L, Gleason JL, Yang Y, et al. (2009) Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med. 206(8):1709–16. doi: 10.1084/jem.20081779 19581406; PubMed Central PMCID: PMCPMC2722178.
43. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA, et al. (2009) NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5(7):e1000500. doi: 10.1371/journal.ppat.1000500 19578435; PubMed Central PMCID: PMCPMC2698121.
44. Kobayashi K, Sudiarta IP, Kodama T, Fukushima T, Ara K, Ozaki K, et al. (2012) Identification and characterization of a novel polysaccharide deacetylase C (PdaC) from Bacillus subtilis. J Biol Chem. 287(13):9765–76. doi: 10.1074/jbc.M111.329490 22277649; PubMed Central PMCID: PMCPMC3323032.
45. Bera A, Biswas R, Herbert S, Kulauzovic E, Weidenmaier C, Peschel A, et al. (2007) Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 189(1):280–3. doi: 10.1128/JB.01221-06 17085565; PubMed Central PMCID: PMCPMC1797201.
46. Atilano ML, Pereira PM, Yates J, Reed P, Veiga H, Pinho MG, et al. (2010) Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A. 107(44):18991–6. doi: 10.1073/pnas.1004304107 20944066; PubMed Central PMCID: PMCPMC2973906.
47. Filipe SR, Severina E, Tomasz A, (2001) The role of murMN operon in penicillin resistance and antibiotic tolerance of Streptococcus pneumoniae. Microb Drug Resist. 7(4):303–16. doi: 10.1089/10766290152773310 11822770.
48. Burke TP, Loukitcheva A, Zemansky J, Wheeler R, Boneca IG, Portnoy DA, (2014) Listeria monocytogenes is resistant to lysozyme through the regulation, not the acquisition, of cell wall-modifying enzymes. J Bacteriol. 196(21):3756–67. doi: 10.1128/JB.02053-14 25157076; PubMed Central PMCID: PMCPMC4248804.
49. Ho TD, Hastie JL, Intile PJ, Ellermeier CD, (2011) The Bacillus subtilis extracytoplasmic function sigma factor sigma(V) is induced by lysozyme and provides resistance to lysozyme. J Bacteriol. 193(22):6215–22. doi: 10.1128/JB.05467-11 21856855; PubMed Central PMCID: PMCPMC3209206.
50. Kraus D, Kalbacher H, Buschmann J, Berger-Bachi B, Gotz F, Peschel A, (2007) Muropeptide modification-amidation of peptidoglycan D-glutamate does not affect the proinflammatory activity of Staphylococcus aureus. Infect Immun. 75(4):2084–7. doi: 10.1128/IAI.01576-06 17261607; PubMed Central PMCID: PMCPMC1865678.
51. Figueiredo TA, Sobral RG, Ludovice AM, Almeida JM, Bui NK, Vollmer W, et al. (2012) Identification of genetic determinants and enzymes involved with the amidation of glutamic acid residues in the peptidoglycan of Staphylococcus aureus. PLoS Pathog. 8(1):e1002508. doi: 10.1371/journal.ppat.1002508 22303291; PubMed Central PMCID: PMCPMC3267633.
52. Figueiredo TA, Ludovice AM, Sobral RG, (2014) Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus. Microb Drug Resist. 20(3):238–49. doi: 10.1089/mdr.2014.0042 24799330; PubMed Central PMCID: PMCPMC4050451.
53. Veiga P, Erkelenz M, Bernard E, Courtin P, Kulakauskas S, Chapot-Chartier MP, (2009) Identification of the asparagine synthase responsible for D-Asp amidation in the Lactococcus lactis peptidoglycan interpeptide crossbridge. J Bacteriol. 191(11):3752–7. doi: 10.1128/JB.00126-09 19329637; PubMed Central PMCID: PMCPMC2681893.
54. Muraki M, Morikawa M, Jigami Y, Tanaka H, (1989) A structural requirement in the subsite F of lysozyme. The role of arginine 115 in human lysozyme revealed by site-directed mutagenesis. Eur J Biochem. 179(3):573–9. 2493374.
55. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F, (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem. 274(13):8405–10. 10085071.
56. Herbert S, Bera A, Nerz C, Kraus D, Peschel A, Goerke C, et al. (2007) Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3(7):e102. doi: 10.1371/journal.ppat.0030102 17676995; PubMed Central PMCID: PMCPMC1933452.
57. Le Jeune A, Torelli R, Sanguinetti M, Giard JC, Hartke A, Auffray Y, et al. (2010) The extracytoplasmic function sigma factor SigV plays a key role in the original model of lysozyme resistance and virulence of Enterococcus faecalis. PLoS ONE. 5(3):e9658. doi: 10.1371/journal.pone.0009658 20300180; PubMed Central PMCID: PMCPMC2836378.
58. Wydau-Dematteis S, Louis M, Zahr N, Lai-Kuen R, Saubamea B, Butel MJ, et al. (2015) The functional dlt operon of Clostridium butyricum controls the D-alanylation of cell wall components and influences cell septation and vancomycin-induced lysis. Anaerobe. 35(Pt B):105–14. doi: 10.1016/j.anaerobe.2015.09.001 26363197.
59. Woods EC, Nawrocki KL, Suarez JM, McBride SM, (2016) The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor sigmaV in Response to Lysozyme. Infect Immun. 84(6):1902–16. doi: 10.1128/IAI.00207-16 27068095; PubMed Central PMCID: PMCPMC4907151.
60. Abachin E, Poyart C, Pellegrini E, Milohanic E, Fiedler F, Berche P, et al. (2002) Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol. 43(1):1–14. 11849532.
61. Fittipaldi N, Sekizaki T, Takamatsu D, Harel J, Dominguez-Punaro Mde L, Von Aulock S, et al. (2008) D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect Immun. 76(8):3587–94. doi: 10.1128/IAI.01568-07 18474639; PubMed Central PMCID: PMCPMC2493214.
62. Maloney E, Stankowska D, Zhang J, Fol M, Cheng QJ, Lun S, et al. (2009) The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 5(7):e1000534. doi: 10.1371/journal.ppat.1000534 19649276; PubMed Central PMCID: PMCPMC2713425.
63. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 193(9):1067–76. 11342591; PubMed Central PMCID: PMCPMC2193429.
64. Needham BD, Trent MS, (2013) Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol. 11(7):467–81. doi: 10.1038/nrmicro3047 23748343.
65. Derde M, Nau F, Lechevalier V, Guerin-Dubiard C, Paboeuf G, Jan S, et al. (2015) Native lysozyme and dry-heated lysozyme interactions with membrane lipid monolayers: lateral reorganization of LPS monolayer, model of the Escherichia coli outer membrane. Biochim Biophys Acta. 1848(1 Pt A):174–83. doi: 10.1016/j.bbamem.2014.10.026 25450345.
66. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock RE, (2011) The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother. 55(8):3743–51. doi: 10.1128/AAC.00256-11 21646482; PubMed Central PMCID: PMCPMC3147623.
67. Napier BA, Burd EM, Satola SW, Cagle SM, Ray SM, McGann P, et al. (2013) Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. MBio. (3):e00021–13. doi: 10.1128/mBio.00021-13 23695834; PubMed Central PMCID: PMCPMC3663567.
68. Handing JW, Criss AK, (2015) The lipooligosaccharide-modifying enzyme LptA enhances gonococcal defence against human neutrophils. Cell Microbiol. 17(6):910–21. doi: 10.1111/cmi.12411 25537831; PubMed Central PMCID: PMCPMC4437829.
69. Lewis LA, Choudhury B, Balthazar JT, Martin LE, Ram S, Rice PA, et al. (2009) Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun. 77(3):1112–20. doi: 10.1128/IAI.01280-08 19114544; PubMed Central PMCID: PMCPMC2643632.
70. Heidrich C, Ursinus A, Berger J, Schwarz H, Holtje JV, (2002) Effects of Multiple Deletions of Murein Hydrolases on Viability, Septum Cleavage, and Sensitivity to Large Toxic Molecules in Escherichia coli. Journal of Bacteriology. 184(22):6093–9. doi: 10.1128/JB.184.22.6093-6099.2002 12399477
71. Williams AH, Wheeler R, Thiriau C, Haouz A, Taha MK, Boneca IG, (2017) Bulgecin A: The Key to a Broad-Spectrum Inhibitor That Targets Lytic Transglycosylases. Antibiotics (Basel). 6(1). doi: 10.3390/antibiotics6010008 28241458; PubMed Central PMCID: PMCPMC5372988.
72. Clarke AJ, (1993) Extent of peptidoglycan O acetylation in the tribe Proteeae. J Bacteriol. 175(14):4550–3. 8331084; PubMed Central PMCID: PMCPMC204898.
73. Clarke CA, Scheurwater EM, Clarke AJ, (2010) The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J Biol Chem. 285(20):14843–7. doi: 10.1074/jbc.C110.120931 20351104; PubMed Central PMCID: PMCPMC2865275.
74. Monchois V, Abergel C, Sturgis J, Jeudy S, Claverie JM, (2001) Escherichia coli ykfE ORFan gene encodes a potent inhibitor of C-type lysozyme. J Biol Chem. 276(21):18437–41. doi: 10.1074/jbc.M010297200 11278658.
75. Abergel C, Monchois V, Byrne D, Chenivesse S, Lembo F, Lazzaroni JC, et al. (2007) Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria. Proc Natl Acad Sci U S A. 104(15):6394–9. doi: 10.1073/pnas.0611019104 17405861; PubMed Central PMCID: PMCPMC1847508.
76. Derbise A, Pierre F, Merchez M, Pradel E, Laouami S, Ricard I, et al. (2013) Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response. J Infect Dis. 207(10):1535–43. doi: 10.1093/infdis/jit057 23402825.
77. Callewaert L, Van Herreweghe JM, Vanderkelen L, Leysen S, Voet A, Michiels CW, (2012) Guards of the great wall: bacterial lysozyme inhibitors. Trends Microbiol. 20(10):501–10. doi: 10.1016/j.tim.2012.06.005 22840966.
78. Humbert MV, Awanye AM, Lian LY, Derrick JP, Christodoulides M, (2017) Structure of the Neisseria Adhesin Complex Protein (ACP) and its role as a novel lysozyme inhibitor. PLoS Pathog. 13(6):e1006448. doi: 10.1371/journal.ppat.1006448 28662181.
79. Liu M, Haenssler E, Uehara T, Losick VP, Park JT, Isberg RR, (2012) The Legionella pneumophila EnhC protein interferes with immunostimulatory muramyl peptide production to evade innate immunity. Cell Host Microbe. 12(2):166–76. doi: 10.1016/j.chom.2012.06.004 22901537; PubMed Central PMCID: PMCPMC3678716.
80. Arai R, Fukui S, Kobayashi N, Sekiguchi J, (2012) Solution structure of IseA, an inhibitor protein of DL-endopeptidases from Bacillus subtilis, reveals a novel fold with a characteristic inhibitory loop. J Biol Chem. 287(53):44736–48. doi: 10.1074/jbc.M112.414763 23091053; PubMed Central PMCID: PMCPMC3531787.
81. Daigle F, Graham JE, Curtiss R III, (2001) Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS). Mol Microbiol. 41(5):1211–22. 11555299.
82. Guariglia-Oropeza V, Helmann JD, (2011) Bacillus subtilis sigma(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids. J Bacteriol. 193(22):6223–32. doi: 10.1128/JB.06023-11 21926231; PubMed Central PMCID: PMCPMC3209214.
83. Hastie JL, Williams KB, Sepulveda C, Houtman JC, Forest KT, Ellermeier CD, (2014) Evidence of a bacterial receptor for lysozyme: binding of lysozyme to the anti-sigma factor RsiV controls activation of the ecf sigma factor sigmaV. PLoS Genet. 10(10):e1004643. doi: 10.1371/journal.pgen.1004643 25275625; PubMed Central PMCID: PMCPMC4183432.
84. Hastie JL, Williams KB, Bohr LL, Houtman JC, Gakhar L, Ellermeier CD, (2016) The Anti-sigma Factor RsiV Is a Bacterial Receptor for Lysozyme: Co-crystal Structure Determination and Demonstration That Binding of Lysozyme to RsiV Is Required for sigmaV Activation. PLoS Genet. 12(9):e1006287. doi: 10.1371/journal.pgen.1006287 27602573; PubMed Central PMCID: PMCPMC5014341.
85. Varahan S, Iyer VS, Moore WT, Hancock LE, (2013) Eep confers lysozyme resistance to enterococcus faecalis via the activation of the extracytoplasmic function sigma factor SigV. J Bacteriol. 195(14):3125–34. doi: 10.1128/JB.00291-13 23645601; PubMed Central PMCID: PMCPMC3697634.
86. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M, (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol. 66(5):1136–47. doi: 10.1111/j.1365-2958.2007.05986.x 17961141.
87. Mandin P, Fsihi H, Dussurget O, Vergassola M, Milohanic E, Toledo-Arana A, et al. (2005) VirR, a response regulator critical for Listeria monocytogenes virulence. Mol Microbiol. 57(5):1367–80. doi: 10.1111/j.1365-2958.2005.04776.x 16102006.
88. Allen JP, Neely MN, (2011) The Streptococcus iniae transcriptional regulator CpsY is required for protection from neutrophil-mediated killing and proper growth in vitro. Infect Immun. 79(11):4638–48. doi: 10.1128/IAI.05567-11 21911465; PubMed Central PMCID: PMCPMC3257949.
89. Allen JP, Neely MN, (2012) CpsY influences Streptococcus iniae cell wall adaptations important for neutrophil intracellular survival. Infect Immun. 80(5):1707–15. doi: 10.1128/IAI.00027-12 22354020; PubMed Central PMCID: PMCPMC3347441.
90. Veiga P, Bulbarela-Sampieri C, Furlan S, Maisons A, Chapot-Chartier MP, Erkelenz M, et al. (2007) SpxB regulates O-acetylation-dependent resistance of Lactococcus lactis peptidoglycan to hydrolysis. J Biol Chem. 282(27):19342–54. doi: 10.1074/jbc.M611308200 17485463.
91. Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, Potter JL, et al. (2005) Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol. 56(2):492–508. doi: 10.1111/j.1365-2958.2005.04553.x 15813739.
92. Burke TP, Portnoy DA, (2016) SpoVG Is a Conserved RNA-Binding Protein That Regulates Listeria monocytogenes Lysozyme Resistance, Virulence, and Swarming Motility. MBio. 7(2):e00240. doi: 10.1128/mBio.00240-16 27048798; PubMed Central PMCID: PMCPMC4959528.
93. Wang G, Olczak A, Forsberg LS, Maier RJ, (2009) Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori. J Biol Chem. 284(11):6790–800. doi: 10.1074/jbc.M808071200 19147492; PubMed Central PMCID: PMCPMC2652260.
94. Austin CM, Maier RJ, (2013) Aconitase-mediated posttranscriptional regulation of Helicobacter pylori peptidoglycan deacetylase. J Bacteriol. 195(23):5316–22. doi: 10.1128/JB.00720-13 24056106; PubMed Central PMCID: PMCPMC3837956.
95. Markart P, Faust N, Graf T, Na CL, Weaver TE, Akinbi HT, (2004) Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P. Biochem J. 380(Pt 2):385–92. doi: 10.1042/BJ20031810 14977423; PubMed Central PMCID: PMCPMC1224176.
96. Davis KM, Nakamura S, Weiser JN, (2011) Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest. 121(9):3666–76. doi: 10.1172/JCI57761 21841315; PubMed Central PMCID: PMCPMC3163965.
97. Masumoto J, Yang K, Varambally S, Hasegawa M, Tomlins SA, Qiu S, et al. (2006) Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med. 203(1):203–13. doi: 10.1084/jem.20051229 16418393; PubMed Central PMCID: PMCPMC2118074.
98. Caruso R, Warner N, Inohara N, Nunez G, (2014) NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 41(6):898–908. doi: 10.1016/j.immuni.2014.12.010 25526305; PubMed Central PMCID: PMCPMC4272446.
99. Rosenthal RS, (1979) Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities. Infect Immun. 24(3):869–78. 112060; PubMed Central PMCID: PMCPMC414388.
100. Nigro G, Fazio LL, Martino MC, Rossi G, Tattoli I, Liparoti V, et al. (2008) Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell Microbiol. 10(3):682–95. doi: 10.1111/j.1462-5822.2007.01075.x 18042252.
101. Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, et al. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem. 278(43):41702–8. doi: 10.1074/jbc.M307198200 12871942.
102. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 278(8):5509–12. doi: 10.1074/jbc.C200673200 12514169.
103. Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK, (2012) The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J Am Chem Soc. 134(33):13535–7. doi: 10.1021/ja303883c 22857257; PubMed Central PMCID: PMCPMC3424850.
104. Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA, (2012) Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J Biol Chem. 287(27):23057–67. doi: 10.1074/jbc.M112.344283 22549783; PubMed Central PMCID: PMCPMC3391102.
105. Boyle JP, Parkhouse R, Monie TP, (2014) Insights into the molecular basis of the NOD2 signalling pathway. Open Biol. 4(12). doi: 10.1098/rsob.140178 25520185; PubMed Central PMCID: PMCPMC4281710.
106. Grimes CL, Podolsky DK, O'Shea EK, (2010) Synthesis of biologically active biotinylated muramyl dipeptides. Bioorg Med Chem Lett. 20(20):6061–3. doi: 10.1016/j.bmcl.2010.08.056 20822907; PubMed Central PMCID: PMCPMC2957841.
107. Melnyk JE, Mohanan V, Schaefer AK, Hou CW, Grimes CL, (2015) Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2. J Am Chem Soc. 137(22):6987–90. doi: 10.1021/jacs.5b01607 26035228.
108. Matsumoto K, Ogawa H, Kusama T, Nagase O, Sawaki N, Inage M, et al. (1981) Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice. Infect Immun. 32(2):748–58. 7019079; PubMed Central PMCID: PMCPMC351510.
109. Inamura S, Fujimoto Y, Kawasaki A, Shiokawa Z, Woelk E, Heine H, et al. (2006) Synthesis of peptidoglycan fragments and evaluation of their biological activity. Org Biomol Chem. 4(2):232–42. doi: 10.1039/b511866b 16391765.
110. Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, et al. (2006) Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2(9):e97. doi: 10.1371/journal.ppat.0020097 17002496; PubMed Central PMCID: PMCPMC1574363.
111. Knilans KJ, Hackett KT, Anderson JE, Weng C, Dillard JP, Duncan JA, (2017) Neisseria gonorrhoeae lytic transglycosylases LtgA and LtgD reduce host innate immune signaling through TLR2 and NOD2. ACS Infect Dis. doi: 10.1021/acsinfecdis.6b00088 28585815.
112. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN, (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 16(2):228–31. doi: 10.1038/nm.2087 20081863; PubMed Central PMCID: PMCPMC4497535.
113. Lysenko ES, Clarke TB, Shchepetov M, Ratner AJ, Roper DI, Dowson CG, et al. (2007) Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing. PLoS Pathog. 3(8):e118. doi: 10.1371/journal.ppat.0030118 17722978; PubMed Central PMCID: PMCPMC1950946.
114. Iyer JK, Khurana T, Langer M, West CM, Ballard JD, Metcalf JP, et al. (2010) Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal trafficking. Infect Immun. 78(6):2418–28. doi: 10.1128/IAI.00170-10 20308305; PubMed Central PMCID: PMCPMC2876538.
115. Zhang Q, Pan Y, Yan R, Zeng B, Wang H, Zhang X, et al. (2015) Commensal bacteria direct selective cargo sorting to promote symbiosis. Nat Immunol. 16(9):918–26. doi: 10.1038/ni.3233 26237551.
116. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G, (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 276(7):4812–8. doi: 10.1074/jbc.M008072200 11087742.
117. Lee J, Tattoli I, Wojtal KA, Vavricka SR, Philpott DJ, Girardin SE, (2009) pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J Biol Chem. 284(35):23818–29. doi: 10.1074/jbc.M109.033670 19570976; PubMed Central PMCID: PMCPMC2749154.
118. Nakamura N, Lill JR, Phung Q, Jiang Z, Bakalarski C, de Maziere A, et al. (2014) Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature. 509(7499):240–4. doi: 10.1038/nature13133 24695226.
119. Iyer JK, Coggeshall KM, (2011) Cutting edge: primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J Immunol. 186(7):3841–5. doi: 10.4049/jimmunol.1004058 21357534; PubMed Central PMCID: PMCPMC3071148.
120. Canton J, Schlam D, Breuer C, Gutschow M, Glogauer M, Grinstein S, (2016) Calcium-sensing receptors signal constitutive macropinocytosis and facilitate the uptake of NOD2 ligands in macrophages. Nat Commun. 7:11284. doi: 10.1038/ncomms11284 27050483; PubMed Central PMCID: PMCPMC4823870.
121. Wolf AJ, Arruda A, Reyes CN, Kaplan AT, Shimada T, Shimada K, et al. (2011) Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J Immunol. 187(11):6002–10. doi: 10.4049/jimmunol.1100232 22031762; PubMed Central PMCID: PMCPMC3221871.
122. Lemon JK, Weiser JN, (2015) Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin. MBio. 6(1). doi: 10.1128/mBio.02110-14 25604786; PubMed Central PMCID: PMCPMC4313911.
123. Herskovits AA, Auerbuch V, Portnoy DA, (2007) Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 3(3):e51. doi: 10.1371/journal.ppat.0030051 17397264; PubMed Central PMCID: PMCPMC1839167.
124. Muller S, Wolf AJ, Iliev ID, Berg BL, Underhill DM, Liu GY, (2015) Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology. Cell Host Microbe. 18(5):604–12. doi: 10.1016/j.chom.2015.10.011 26567511; PubMed Central PMCID: PMCPMC4648675.
125. Hedl M, Abraham C, (2013) NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation. Am J Physiol Gastrointest Liver Physiol. 304(6):G583–96. doi: 10.1152/ajpgi.00297.2012 23287275; PubMed Central PMCID: PMCPMC3602688.
126. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, et al. (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A. 105(22):7803–8. doi: 10.1073/pnas.0802726105 18511561; PubMed Central PMCID: PMCPMC2409384.
127. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, et al. (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell. 25(5):713–24. doi: 10.1016/j.molcel.2007.01.032 17349957.
128. Wolf AJ, Reyes CN, Liang W, Becker C, Shimada K, Wheeler ML, et al. (2016) Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan. Cell. 166(3):624–36. doi: 10.1016/j.cell.2016.05.076 27374331.
129. Ganz T, Gabayan V, Liao HI, Liu L, Oren A, Graf T, et al. (2003) Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood. 101(6):2388–92. doi: 10.1182/blood-2002-07-2319 12411294.
130. Markart P, Korfhagen TR, Weaver TE, Akinbi HT, (2004) Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Am J Respir Crit Care Med. 169(4):454–8. doi: 10.1164/rccm.200305-669OC 14617511.
131. Shimada J, Moon SK, Lee HY, Takeshita T, Pan H, Woo JI, et al. (2008) Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis. 8:134. doi: 10.1186/1471-2334-8-134 18842154; PubMed Central PMCID: PMCPMC2575207.
132. Wang H, Zhang X, Zuo Z, Zhang Q, Pan Y, Zeng B, et al. (2017) Rip2 Is Required for Nod2-Mediated Lysozyme Sorting in Paneth Cells. J Immunol. 198(9):3729–36. doi: 10.4049/jimmunol.1601583 28330897.
133. Lee M, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y, (2009) Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Agric Food Chem. 57(6):2233–40. doi: 10.1021/jf803133b 19231858.
134. Gordon LI, Douglas SD, Kay NE, Yamada O, Osserman EF, Jacob HS, (1979) Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest. 64(1):226–32. doi: 10.1172/JCI109443 221543; PubMed Central PMCID: PMCPMC372109.
135. Ogundele MO, (1998) A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediators Inflamm. 7(5):363–5. doi: 10.1080/09629359890893 9883972; PubMed Central PMCID: PMCPMC1781862.
136. Liu H, Zheng F, Cao Q, Ren B, Zhu L, Striker G, et al. (2006) Amelioration of oxidant stress by the defensin lysozyme. Am J Physiol Endocrinol Metab. 290(5):E824–32. doi: 10.1152/ajpendo.00349.2005 16317028.
137. Li YM, Tan AX, Vlassara H, (1995) Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med. 1(10):1057–61. 7489363.
138. Riber U, Espersen F, Wilkinson BJ, Kharazmi A, (1990) Neutrophil chemotactic activity of peptidoglycan. A comparison between Staphylococcus aureus and Staphylococcus epidermidis. APMIS. 98(10):881–6. 2245008.